A61Q19/06

LIPOSOMES, EMULSIONS, AND METHODS FOR CRYOTHERAPY

A method and system in accordance with a particular embodiments of the technology includes applying a substance onto skin of a human subject. The applied substance can include a freezing point depressant and a liposome, an oil-in-water emulsion, a water-in-oil emulsion, or an oil-in-oil emulsion and can be configured to protect or target tissue. The substance and a surface of the skin can be cooled using the applicator to treat acne and other skin conditions.

LIPOSOMES, EMULSIONS, AND METHODS FOR CRYOTHERAPY

A method and system in accordance with a particular embodiments of the technology includes applying a substance onto skin of a human subject. The applied substance can include a freezing point depressant and a liposome, an oil-in-water emulsion, a water-in-oil emulsion, or an oil-in-oil emulsion and can be configured to protect or target tissue. The substance and a surface of the skin can be cooled using the applicator to treat acne and other skin conditions.

COMPOSITIONS AND METHODS COMPRISING SANSHOOL AS LIP INTERACTING COMPONENTS
20240115526 · 2024-04-11 ·

Provided are compositions and methods comprising a sanshool for the treatment of obesity as part of a controlled diet regime in an individual. Also provided are compositions and methods comprising a sanshool for treatment of a smoking or vaping addiction. Suitably the compositions are applied topically to the lips of the individual in response to a habitual urge to consume food, smoke or vape as required.

Lupin peptide extracts and skin firmness

The present invention relates to the use of a lupin peptide extract to prevent loss of skin firmness or to increase the firmness of skin. Advantageously, the lupin peptide extract can prevent the appearance of cellulite and/or reduce skin cellulite.

Lupin peptide extracts and skin firmness

The present invention relates to the use of a lupin peptide extract to prevent loss of skin firmness or to increase the firmness of skin. Advantageously, the lupin peptide extract can prevent the appearance of cellulite and/or reduce skin cellulite.

SELECTIVE FAT REMOVAL USING PHOTOTHERMAL HEATING
20190321099 · 2019-10-24 ·

A system and method are provided for minimally-invasive selective fat removal from a target area by injecting the area with a solution of photo-absorbing nanoparticles and irradiating the injected area with a beam of near infrared (NIR) light. The NIR emission wavelength excites the nanoparticles to melt fat within the target area so that the liquefied fat can be aspirated from the target area. The nanoparticles may be gold nanorods having aspect ratios selected to produce surface plasmon resonance when irradiated with NIR light around 800 nm.

COSMETIC COMPOSITIONS AND USES THEREOF
20190307654 · 2019-10-10 ·

Disclosed is a method for reducing the appearance of cellulite or improving the texture of skin in a target region of skin that has cellulite or rough skin texture, the method comprising topically applying a composition to the target region that includes an effective amount of a mixture of caffeine, escin, and an extract from Ascophyllum nodosum, wherein topical application of the composition reduces the appearance of cellulite or improves the texture of the skin.

COSMETIC COMPOSITIONS AND USES THEREOF
20190307654 · 2019-10-10 ·

Disclosed is a method for reducing the appearance of cellulite or improving the texture of skin in a target region of skin that has cellulite or rough skin texture, the method comprising topically applying a composition to the target region that includes an effective amount of a mixture of caffeine, escin, and an extract from Ascophyllum nodosum, wherein topical application of the composition reduces the appearance of cellulite or improves the texture of the skin.

Alkylamido Compounds and Uses Thereof
20190269637 · 2019-09-05 ·

Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same.

Alkylamido Compounds and Uses Thereof
20190269637 · 2019-09-05 ·

Disclosed herein are compounds that may be specific to PPAR and/or EGF receptors, and methods of making and using same.